Breast cancer is the second leading cause of cancer death and the most frequently diagnosed form of cancer among women in the United States. According to the most recent publication from the American Cancer Society, in 2008, an estimated 182,462 new cases of invasive breast cancer will be diagnosed among women, and approximately 40,480 women are expected to die from this disease. The etiology of breast cancer remains to be fully explained, with less than 50% of the cases attributed to known risk factors (1). Several potential risk factors including genetic components, diet, smoking, alcohol intake, and physical activity, have been identified (28).
It has been suggested that physical activity, one of the few established modifiable breast cancer risk factors, may protect against both the development of the disease (9,36,37,39) and the progression after diagnosis (19,27). A recent systematic review by Monninkhof et al. (30) found evidence of an extreme inverse association between physical activity and breast cancer in postmenopausal women; that is, equivalent to a 20-80% decrease in risk of incident disease. Differences in risk estimates may result from imprecise physical activity assessment collected from self-report instruments, especially in women (3). In addition, most of previous studies have reported on either physical activity and incident (9,37) or combined fatal/nonfatal (36,39) breast cancer. Because physical activity protects against incident breast cancer (9,12,18,37), it might be reasonable to expect that physical activity would confer protection against fatal breast cancer. However, this inference cannot confidently be drawn from studies of combined nonfatal/fatal events or studies solely reliant on nonfatal outcomes. To the best of our knowledge, no study has been conducted on cardiorespiratory fitness (CRF), an objective and reproducible measure that reflects the functional consequences of physical activity habits, short-term effects of disease status (e.g., respiratory tract infections), and genetics (21). We therefore examined the association between CRF, objectively measured by maximal exercise test on a treadmill, and breast cancer mortality in women from the Aerobic Center Longitudinal Study (ACLS).
The population for the current analysis was composed of primarily white (>99%), married, well-educated women with no prior history of breast cancer. These women, ranging in age from 20 to 83 yr, received a preventive medical examination at the Cooper Clinic in Dallas, Texas, between 1970 and 2001 (N = 14,811). Study participants came to the clinic for periodic preventive health examinations and to receive counseling regarding diet, exercise, and other lifestyle factors associated with increased risk of chronic disease. Many participants were sent by their employers for the examination, some were referred by their personal physicians, and the rest were self-referred. At baseline, all participants were able to complete an exercise stress test to at least 85% of their age-predicted maximal heart rate (220 minus age in years). The study protocol was approved annually by the Institutional Review Board of the Cooper Institute.
The baseline clinical examination was performed after receiving written informed consent from each participant and included fasting blood chemistry analyses, personal and family health history, anthropometry, resting blood pressure and ECG, and a maximal graded exercise test. Examination methods and procedures followed a standard manual of operations, as described previously (6). Briefly, body mass index [BMI = weight (kg) / height (m)2] was computed from measured height and weight. Resting blood pressure was recorded as the first and the fifth Korotkoff sounds by auscultatory methods. Serum samples were analyzed for lipids and glucose using standardized automated bioassays by a laboratory that participates in and meets quality control standards of the CDC Lipid Standardization Program. Information on smoking habits (whether a current smoker), alcohol intake (number of drinks per week), personal history of cardiovascular disease (myocardial infarction or stroke), hypertension and diabetes, family history of breast cancer, oral contraceptive use, and exogenous estrogen use was obtained from a standardized questionnaire.
CRF was assessed at the baseline examination as the duration of a symptom-limited maximal treadmill exercise test using a modified Balke protocol (5,6). The treadmill speed was 88 m·min−1 for the first 25 min. During this time, the grade was 0% for the first minute, 2% the second minute, and increased 1% each minute until 25 min had elapsed. After 25 min, the grade remained constant whereas the speed increased 5.4 m·min−1 each minute until test termination. Patients were encouraged to give a maximal effort during the test. The mean (SD) percentage of age-predicted maximal heart rate achieved during exercise was 100.0 (6.3). The duration of the maximal exercise treadmill test on this protocol is highly correlated with directly measured maximal oxygen uptake in women (r = 0.94), an accepted measure of CRF (32). Maximal METs (1 MET = 3.5 mL O2 uptake·kg−1·min−1) were estimated from the final treadmill speed and grade (4). We used our previously published age-specific distribution of treadmill duration from the overall ACLS population to define fitness groups as low (lowest 20%), moderate (middle 40%), and high (upper 40%) to maintain consistency in the study methods and because we have found that a low level of fitness, defined in this way, is an independent predictor of mortality (6) and morbidity (38). The respective cut points for total treadmill time and METs in the low, moderate, and high fitness groups were described in detail in a recent report (38).
Abnormal exercise ECG responses were broadly defined as rhythm and conduction disturbances and ischemic ST-T wave abnormalities as described in detail elsewhere (13). We have found 90% agreement between the ECG interpretation recorded in our database and that of a group of three physicians who read a random sample of 357 patient records (13).
All participants were followed from the date of their baseline examination until their date of death or December 31, 2003. The National Death Index (NDI) was the primary data source for mortality surveillance. The underlying cause of death was determined from the NDI report or by a nosologist's review of official death certificates obtained from the department of vital records in the decedent's state of residence. Breast cancer mortality was defined by the International Classification of Diseases, Ninth Revision (ICD-9) codes 174 to 175 before 1999 and Tenth Revision (ICD-10) codes C50 during 1999-2003. We computed woman-years of exposure as the sum of follow-up time among decedents and survivors.
Baseline characteristics of the population were calculated for the entire cohort and by CRF groups. Differences in covariates were assessed using F-tests. Kaplan-Meier plots were used to compare survival curves, and Cox proportional hazards models were used to estimate adjusted hazard ratios (HR), associated 95% confidence intervals (CI), mortality rates (deaths/10,000 woman-years of follow-up), and linear trends of breast cancer mortality for levels of each fitness category. When calculating HR, the low fitness group was used as the reference category. Multivariable-adjusted models controlled for the potential confounding effects of baseline age (yr), BMI (kg·m−2), smoking (current smoker or not), alcohol intake (five or more drinks per week or not), chronic conditions (cardiovascular disease, hypertension or diabetes, present or not for each), family history of breast cancer (present or not), abnormal exercise ECG responses (present or not), oral contraceptive use (yes or no), and estrogen use (yes or no). Cumulative hazard plots grouped by exposure suggested no appreciable violations of the proportional hazards assumption.
We also conducted Cox regression analyses of CRF stratified by categories of age, BMI, oral contraceptive use, and estrogen use to assess whether the associations were stronger in particular subgroups. Tests for multiplicative interaction between an increment of 1 min of MET of exercise capacity and other risk factors in relation to risk of breast cancer death were assessed using likelihood ratio tests comparing the models with or without interaction terms. We examined the risk of breast cancer across increments of METs to assess the shape of the fitness-breast cancer curve. Statistical analyses were performed using SAS (version 9.1, SAS Institute, Cary, NC) software. All P values were calculated from two-sided hypothesis tests, and CI were calculated at the 95% level.
At baseline, the mean (SD) age of the study participants was 43.0 (10.5) yr, the mean (SD) treadmill test duration was 13.3 (4.7) min, and the mean (SD) maximal METs was 9.5 (2.2). The distribution of participant characteristics for several breast cancer risk factors is given in Table 1 across categories of CRF. Women in the high fitness group were more likely to have a lower BMI, to have a more favorable lipid and blood pressure profile, to have a healthier lifestyle (as reflected by smoking and alcohol intake), and to have a lower rate of chronic conditions (as reflected by cardiovascular disease, hypertension, diabetes, and abnormal exercise ECG) as compared with low CRF.
In a mean length of 16.4 yr (range = 1.01-33.7 yr) follow-up and 242,900 woman-years of observation, 68 breast cancer deaths were identified. A steep inverse gradient (Ptrend = 0.008) of breast cancer mortality rates was observed across CRF groups (Table 2). After adjusting for covariates (age, BMI, current smoking, alcohol intake, chronic conditions, family history of breast cancer, abnormal exercise ECG, and oral contraceptive and estrogen use), women with moderate and high CRF had 33% and 55% lower breast cancer risk, respectively, than did women with low CRF (Ptrend = 0.04). The Kaplan-Meier plot depicts the breast cancer death rates by fitness group (Fig. 1).
We next examined whether other risk predictors modified the association between CRF and breast cancer death (Table 3). After adjustment for age, we observed significantly lower risk of death per 1 MET increment in exercise capacity among younger women (Ptrend = 0.004), women who were normal weight (Ptrend = 0.03), and women who never used oral contraceptives (Ptrend = 0.03) or estrogen replacement (Ptrend = 0.01). The test for interaction was not significant in the subgroups (P for interaction >0.40 for each). These associations between CRF and breast cancer mortality risk according to categories of other risk factors attenuated after controlling each of the other variables shown in the table. The inverse association remained significant only among women who were younger than 55 yr old and those who never used estrogen.
To further examine the dose-response characteristics between CRF levels and breast cancer mortality in our population of women, we computed the age-adjusted death rates (per 10,000 woman-years) for categories of CRF defined by increments of 1 MET across the range of 8 to 10 METs (Fig. 2). An exercise capacity of less than 8 METs was associated with a nearly threefold higher risk of breast cancer mortality compared with women having a capacity of 10 METs and greater (Ptrend = 0.007). The inverse association remained significant after multivariate adjustment (Ptrend = 0.02).
In this study, we observed an inverse association between CRF and the risk of breast cancer mortality. Women in the moderate and high CRF groups demonstrated a 33% and 55% lower risk, respectively, of dying of breast cancer. This association persisted after adjustment of other available potential confounders. Women with an exercise capacity less than 8 METs had a nearly threefold higher risk of dying of breast cancer compared with those with higher METs level (≥8). These data suggest that an exercise capacity of at least 8 METs may be needed to provide substantially protective benefits.
To the best of our knowledge, this is the first prospective cohort study to assess the association of CRF to risk of dying of breast cancer. It is important to note that the vast majority of the literature on breast cancer has focused on incidence and not on mortality of disease. Mortality reflects the combination of incidence with a variety of prognostic factors relating primarily to disease-related characteristics such as stage at diagnosis and grade as well as lifestyle and other factors that might influence outcome. Despite this, death registration is excellent in countries such as the United States, and mortality is a "hard" outcome that we have used with great success in the past (16). It is also important to note that there are literatures relating factors such as diet, physical activity, and relative body weight to both breast cancer incidence (9,10,15,22) and mortality (8,31,40).
Previous cohort studies using self-reported physical activity show lower risks for incident (9,37) or combined fatal/nonfatal (30,36,39) breast cancer ranging from 15% to 40%. However, other studies have reported no association (24,25,34) between physical activity and incident breast cancer. The varying range of effects and the inconsistency of results may be due to the imprecise assessment of physical activity derived from the questionnaires, population differences in the study cohorts, differences in breast cancer end points used, duration of follow-up after the baseline exposure measurement, or some combination of these.
Beyond a CRF level of 8 METs (Fig. 2), it did not appear that there were substantial decreases in risk of breast cancer death. This finding of an apparent CRF threshold adds insight into the relationship between CRF and breast cancer death. A systematic review of physical activity and breast cancer end points (including occurrence and mortality) indicates that approximately half of the selected studies observed a dose-response relationship (30). Thune et al. (39) found that compared with being sedentary, being moderately active during leisure time was associated with a 7% lower breast cancer mortality. Being regularly active during leisure time was associated with a 37% lower breast cancer incidence. These findings indicate an incremental dose-response relationship between self-reported physical activity and breast cancer end points rather than the threshold phenomenon between CRF and breast cancer observed in the present study. It is unclear what contributes to this difference, although the differing approaches to measuring physical activity exposures (i.e., self-reported physical activity vs the more objective CRF) likely account for some of the variability. Future studies are needed to confirm our findings.
A functional capacity of 8 METs is considered a low to moderate level of CRF for women across the adult age spectrum (6,38). Most women can attain this level of CRF by participating in moderate and/or vigorous intensity physical activities for 30 min or more on most days of the week (14). Although CRF has a genetic component (21), it is clear that usual physical activity habits are the primary determinant of fitness. Recently, Church et al. (7) reported that women with an activity level as low as 4 kcal·kg−1·wk−1 level (approximately 72 min·wk−1 of moderate intensity walking) had a significant improvement in CRF compared with women in the nonexercise control group. Therefore, CRF can be enhanced in most individuals through participation in a modest amount of moderate intensity physical activity.
Several biological mechanisms have been proposed to explain how increased physical activity may protect against breast cancer, including the reduction of endogenous reproductive hormone levels, decreases in body weight and adiposity, changes in circulating levels of insulin and insulin-like growth factors, and enhanced immune function (12,17). Unfortunately, we do not have data related to these variables. Therefore, we cannot evaluate these biological mechanisms directly. Due to the unique cohort design of this study, however, our investigation has several properties that enable examination of fitness and physical activity in relation to breast cancer mortality. It is rare to have a measure of fitness in a study of breast cancer and rarer still to obtain that measure before a breast cancer diagnosis. One possible hypothesis is that women maintained their level of fitness after their diagnosis, which then resulted in decreased mortality in the high fitness group. However, previous research among cancer survivors demonstrates that physical activity typically decreases after a cancer diagnosis (26). Thus, observational data do not support this supposition. An alternative hypothesis is that "prediagnosis" fitness could result in a better breast cancer prognosis (i.e., women are diagnosed with less aggressive disease), which could then favorably impact breast cancer mortality. There is some indirect support for this hypothesis from the literature, which has demonstrated a protective effect of physical activity on markers of breast cancer prognosis such as estrogen and progesterone receptor status (2,11). In these studies, physical activity was protective for estrogen and progesterone receptor-negative breast cancer, which is known to be associated with the poorest prognosis and survival. Examination of the relationship of fitness or physical activity with other breast cancer prognostic indicators could be an interesting avenue for future study.
Strengths of the current study include its prospective design, extensive baseline examinations to detect subclinical disease, careful measurement of risk factors (as opposed to self-report), maximal exercise testing to quantify CRF, and a hard end point of breast cancer mortality as the study outcome. A limitation is the inability to adjust for dietary factors and menopausal status due to the lack of data in the current study. However, a recent study that has adjusted for daily caloric intake and percentage of calories from fat found that these adjustments did not significantly change conclusions (29). Although there is evidence that dietary fat may be a stronger risk factor for postmenopausal breast cancer than for premenopausal breast cancer (20), Kushi et al. (23) only found a nonsignificant positive association between dietary fat and risk of postmenopausal breast cancer. According to the latest clinical trial results from the Women's Health Initiative, women following a recommended eating pattern including a reduction in total fat did not experience reduced breast cancer incidence (33). It is possible that residual confounding may exist, although it seems unlikely that it would account for all of the observed association between CRF and breast cancer. Another limitation of the present study is that the hormone receptor status (estrogen or progesterone) and the tumor stage (including in situ) and grade were not available. A recent report from the California Teachers Study shows an inverse association between self-reported physical activity and risk of both invasive and in situ breast cancer in women and an inverse association on estrogen-negative but not estrogen-positive breast cancer (9). Additional research is needed to further understand the specificity of associations between CRF (or physical activity) and breast cancer subtypes. The current findings are limited to European-American women in the middle and upper socioeconomic strata; the results may not be generalizable to other adult populations. Finally, we had no data on the use of mammography screening and current cancer and treatment. Future studies need to include this information to confirm our findings reported here. Given that the cohort was comprised of well-educated women of a high socioeconomic standing, we estimate that the majority of the women were seeking regular mammography screening (35). Thus, we would not anticipate a change in our findings upon adjustment for screening.
In summary, we found an inverse association between CRF and risk of breast cancer mortality in this cohort of US women and that a certain, relatively low, threshold of CRF may be needed. Given the public health burden of breast cancer, future research needs to determine the specific biological aspects of exercise related to breast cancer risk and if a dose-response relationship exists.
The authors thank the Cooper Clinic physicians and technicians for collecting the baseline data and the staff at the Cooper Institute for data entry and data management.
Supported by the National Institutes of Health grants AG06945 and HL62508. Results of the present study do not constitute endorsement by ACSM.
Conflicts of interest: None declared.
1. Adams SA, Hebert JR, Bolick-Aldrich S, et al. Breast cancer disparities in South Carolina: early detection, special programs, and descriptive epidemiology
. J S C Med Assoc
2. Adams SA, Matthews CE, Hebert JR, et al. Association of physical activity
with hormone receptor status: the Shanghai Breast Cancer Study. Cancer Epidemiol Biomarkers Prev
3. Ainsworth BE. Issues in the assessment of physical activity
in women. Res Q Exerc Sport
4. American College of Sports Medicine. ACSM's Guidelines for Exercise Testing and Prescription
. 7th ed. Philadelphia: Lippincott Williams and Wilkins 2005. p. 291-4.
5. Balke B, Ware RW. An experimental study of physical fitness in Air Force personnel. U S Armed Forces Med J
6. Blair SN, Kohl HW 3rd, Paffenbarger RS Jr, Clark DG, Cooper KH,Gibbons LW. Physical fitness and all-cause mortality: a prospective study of healthy men and women. JAMA
7. Church TS, Earnest CP, Skinner JS, Blair SN. Effects of different doses of physical activity
on cardiorespiratory fitness among sedentary, overweight or obese postmenopausal women with elevated blood pressure: a randomized controlled trial. JAMA
8. Daling JR, Malone KE, Doody DR, Johnson LG, Gralow JR, Porter PL. Relation of body mass index to tumor markers and survival among young women with invasive ductal breast carcinoma. Cancer
9. Dallal CM, Sullivan-Halley J, Ross RK, et al. Long-term recreational physical activity
and risk of invasive and in situ
breast cancer: the California teachers study. Arch Intern Med
10. Elias SG, Peeters PH, Grobbee DE, van Noord PA. Breast cancer risk after caloric restriction during the 1944-1945 Dutch famine. J Natl Cancer Inst
11. Enger SM, Ross RK, Paganini-Hill A, Carpenter CL, Bernstein L. Body size, physical activity
, and breast cancer hormone receptor status: results from two case-control studies. Cancer Epidemiol Biomarkers Prev
12. Friedenreich CM, Orenstein MR. Physical activity
and cancer prevention
: etiologic evidence and biological mechanisms. J Nutr
13. Gibbons LW, Mitchell TL, Wei M, Blair SN, Cooper KH. Maximal exercise test as a predictor of risk for mortality from coronary heart disease in asymptomatic men. Am J Cardiol
14. Haskell WL, Leon AS, Caspersen CJ, et al. Cardiovascular benefits and assessment of physical activity
and physical fitness in adults. Med Sci Sports Exerc
. 1992;24(6 Suppl):S201-20.
15. Hebert JR, Hurley TG, Ma Y. The effect of dietary exposures on recurrence and mortality in early stage breast cancer. Breast Cancer Res Treat
16. Hebert JR, Rosen A. Nutritional, socioeconomic, and reproductive factors in relation to female breast cancer mortality: findings from a cross-national study. Cancer Detect Prev
17. Hoffman-Goetz L, Apter D, mark-Wahnefried W, Goran MI, McTiernan A, Reichman ME. Possible mechanisms mediating an association between physical activity
and breast cancer. Cancer
18. Hoffman-Goetz L, Husted J. Exercise and breast cancer: review and critical analysis of the literature. Can J Appl Physiol
19. Holmes MD, Chen WY, Feskanich D, Kroenke CH, Colditz GA. Physical activity
and survival after breast cancer diagnosis. JAMA
20. Howe GR, Hirohata T, Hislop TG, et al. Dietary factors and risk of breast cancer: combined analysis of 12 case-control studies. J Natl Cancer Inst
21. Ingelsson E, Larson MG, Vasan RS, et al. Heritability, linkage, and genetic associations of exercise treadmill test responses. Circulation
22. Kumar NB, Riccardi D, Cantor A, Dalton K, Allen K. A case-control study evaluating the association of purposeful physical activity
, body fat distribution, and steroid hormones on premenopausal breast cancer risk. Breast J
23. Kushi LH, Sellers TA, Potter JD, et al. Dietary fat and postmenopausal breast cancer. J Natl Cancer Inst
24. Lee IM, Rexrode KM, Cook NR, Hennekens CH, Burin JE. Physical activity
and breast cancer risk: the Women's Health Study (United States). Cancer Causes Control
25. Luoto R, Latikka P, Pukkala E, Hakulinen T, Vihko V. The effect of physical activity
on breast cancer risk: a cohort study of 30,548 women. Eur J Epidemiol
26. Lynch BM, Cerin E, Newman B, Owen N. Physical activity
, activity change, and their correlates in a population-based sample of colorectal cancer survivors. Ann Behav Med
27. Matthews CE, Wilcox S, Hanby CL, et al. Evaluation of a 12-week home-based walking intervention for breast cancer survivors. Support. Care Cancer
28. McPherson K, Steel CM, Dixon JM. ABC of breast diseases. Breast cancer-epidemiology
, risk factors, and genetics. BMJ
29. McTiernan A, Kooperberg C, White E, et al. Recreational physical activity
and the risk of breast cancer in postmenopausal women: the Women's Health Initiative Cohort Study. JAMA
30. Monninkhof EM, Elias SG, Vlems FA, et al. Physical activity
and breast cancer: a systematic review. Epidemiology
31. Newman LA, Mason J, Cote D, et al. African-American ethnicity, socioeconomic status, and breast cancer survival: a meta-analysis of 14 studies involving over 10,000 African-American and 40,000 White American patients with carcinoma of the breast. Cancer
32. Pollock ML, Foster C, Schmidt D, Hellman C, Linnerud AC, Ward A. Comparative analysis of physiologic responses to three different maximal graded exercise test protocols in healthy women. Am Heart J
33. Prentice RL, Caan B, Chlebowski RT, et al. Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA
34. Rockhill B, Willett WC, Hunter DJ, Manson JE, Hankinson SE, Colditz GA. A prospective study of recreational physical activity
and breast cancer risk. Arch Intern Med
35. Ryerson AB, Miller JW, Eheman CR, Leadbetter S, White MC. Recent trends in U.S. mammography use from 2000-2006: a population-based analysis. Prev Med
36. Sesso HD, Paffenbarger RS Jr, Lee IM. Physical activity
and breast cancer risk in the College Alumni Health Study (United States). Cancer Causes Control
37. Slattery ML, Edwards S, Murtaugh MA, et al. Physical activity
and breast cancer risk among women in the southwestern United States. Ann Epidemiol
38. Sui X, LaMonte MJ, Blair SN. Cardiorespiratory fitness as a predictor of nonfatal cardiovascular events in asymptomatic women and men. Am J Epidemiol
39. Thune I, Brenn T, Lund E, Gaard M. Physical activity
and the risk of breast cancer. N Engl J Med
40. Whiteman MK, Hillis SD, Curtis KM, McDonald JA, Wingo PA, Marchbanks PA. Body mass and mortality after breast cancer diagnosis. Cancer Epidemiol Biomarkers Prev
Keywords:©2009The American College of Sports Medicine
EPIDEMIOLOGY; PREVENTION; DEATH FROM BREAST CANCER; PHYSICAL ACTIVITY